| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Hsp90 protein binding | 2.59e-09 | 55 | 21 | 5 | GO:0051879 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.32e-08 | 163 | 21 | 6 | GO:0031072 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 2.19e-07 | 12 | 21 | 3 | GO:0004382 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 1.13e-06 | 20 | 21 | 3 | GO:0017110 | |
| GeneOntologyMolecularFunction | spectrin binding | 5.87e-06 | 34 | 21 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | lipopolysaccharide binding | 1.68e-05 | 48 | 21 | 3 | GO:0001530 | |
| GeneOntologyMolecularFunction | cytokine binding | 1.98e-05 | 157 | 21 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | G protein activity | 3.14e-05 | 59 | 21 | 3 | GO:0003925 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 3.39e-05 | 180 | 21 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 3.94e-05 | 187 | 21 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 5.21e-05 | 201 | 21 | 4 | GO:0061135 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 1.35e-04 | 257 | 21 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.50e-04 | 507 | 21 | 5 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.50e-04 | 507 | 21 | 5 | GO:0060589 | |
| GeneOntologyMolecularFunction | GDP binding | 1.66e-04 | 103 | 21 | 3 | GO:0019003 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 4.30e-04 | 1418 | 21 | 7 | GO:0030234 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 9.91e-04 | 435 | 21 | 4 | GO:0004857 | |
| GeneOntologyMolecularFunction | lipid binding | 3.08e-03 | 988 | 21 | 5 | GO:0008289 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 3.14e-03 | 596 | 21 | 4 | GO:0140678 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 5.06e-03 | 337 | 21 | 3 | GO:0031625 | |
| GeneOntologyMolecularFunction | GTPase activity | 5.23e-03 | 341 | 21 | 3 | GO:0003924 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 5.98e-03 | 358 | 21 | 3 | GO:0044389 | |
| GeneOntologyMolecularFunction | GTP binding | 7.95e-03 | 397 | 21 | 3 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.05e-02 | 439 | 21 | 3 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.05e-02 | 439 | 21 | 3 | GO:0019001 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.05e-02 | 839 | 21 | 4 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.05e-02 | 840 | 21 | 4 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.05e-02 | 840 | 21 | 4 | GO:0016818 | |
| GeneOntologyMolecularFunction | actin binding | 1.32e-02 | 479 | 21 | 3 | GO:0003779 | |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 4.84e-09 | 4 | 23 | 3 | GO:0140973 | |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 2.42e-08 | 6 | 23 | 3 | GO:0140971 | |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 6.76e-08 | 8 | 23 | 3 | GO:0140970 | |
| GeneOntologyBiologicalProcess | positive regulation of pyroptotic inflammatory response | 1.01e-07 | 9 | 23 | 3 | GO:0140639 | |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 1.01e-07 | 9 | 23 | 3 | GO:0051715 | |
| GeneOntologyBiologicalProcess | cytolysis | 2.65e-07 | 12 | 23 | 3 | GO:0019835 | |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 1.36e-06 | 20 | 23 | 3 | GO:0044406 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammasome-mediated signaling pathway | 3.10e-06 | 26 | 23 | 3 | GO:0141087 | |
| GeneOntologyBiologicalProcess | defense response to protozoan | 1.08e-05 | 39 | 23 | 3 | GO:0042832 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-beta | 1.26e-05 | 41 | 23 | 3 | GO:0035458 | |
| GeneOntologyBiologicalProcess | response to protozoan | 1.35e-05 | 42 | 23 | 3 | GO:0001562 | |
| GeneOntologyBiologicalProcess | pyroptotic inflammatory response | 1.35e-05 | 42 | 23 | 3 | GO:0070269 | |
| GeneOntologyBiologicalProcess | regulation of inflammasome-mediated signaling pathway | 2.03e-05 | 48 | 23 | 3 | GO:0141085 | |
| GeneOntologyBiologicalProcess | response to interferon-beta | 2.03e-05 | 48 | 23 | 3 | GO:0035456 | |
| GeneOntologyBiologicalProcess | positive regulation of sulfur metabolic process | 2.49e-05 | 7 | 23 | 2 | GO:0051176 | |
| GeneOntologyBiologicalProcess | inflammasome-mediated signaling pathway | 2.74e-05 | 53 | 23 | 3 | GO:0141084 | |
| GeneOntologyBiologicalProcess | positive regulation of pattern recognition receptor signaling pathway | 9.06e-05 | 79 | 23 | 3 | GO:0062208 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex assembly | 1.07e-04 | 227 | 23 | 4 | GO:0031334 | |
| GeneOntologyBiologicalProcess | regulation of sulfur metabolic process | 1.60e-04 | 17 | 23 | 2 | GO:0042762 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid cohesion | 2.23e-04 | 20 | 23 | 2 | GO:0007063 | |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 2.69e-04 | 114 | 23 | 3 | GO:0071346 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 3.86e-04 | 129 | 23 | 3 | GO:0039531 | |
| GeneOntologyBiologicalProcess | disruption of cell in another organism | 3.86e-04 | 129 | 23 | 3 | GO:0141061 | |
| GeneOntologyBiologicalProcess | killing of cells of another organism | 3.86e-04 | 129 | 23 | 3 | GO:0031640 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | 3.87e-04 | 1299 | 23 | 7 | GO:1902533 | |
| GeneOntologyBiologicalProcess | disruption of anatomical structure in another organism | 4.13e-04 | 132 | 23 | 3 | GO:0141060 | |
| GeneOntologyBiologicalProcess | regulation of ERAD pathway | 4.74e-04 | 29 | 23 | 2 | GO:1904292 | |
| GeneOntologyBiologicalProcess | response to type II interferon | 5.01e-04 | 141 | 23 | 3 | GO:0034341 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 6.00e-04 | 150 | 23 | 3 | GO:0050830 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle tissue development | 6.15e-04 | 33 | 23 | 2 | GO:0048641 | |
| GeneOntologyBiologicalProcess | cellular response to biotic stimulus | 6.48e-04 | 364 | 23 | 4 | GO:0071216 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.07e-03 | 416 | 23 | 4 | GO:0030522 | |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 1.15e-03 | 188 | 23 | 3 | GO:0002753 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response | 1.24e-03 | 193 | 23 | 3 | GO:0050729 | |
| GeneOntologyBiologicalProcess | regulation of pattern recognition receptor signaling pathway | 1.24e-03 | 193 | 23 | 3 | GO:0062207 | |
| GeneOntologyCellularComponent | host cell part | 2.32e-08 | 6 | 23 | 3 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 2.32e-08 | 6 | 23 | 3 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 2.32e-08 | 6 | 23 | 3 | GO:0033655 | |
| GeneOntologyCellularComponent | host intracellular region | 2.32e-08 | 6 | 23 | 3 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 2.32e-08 | 6 | 23 | 3 | GO:0030430 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 2.32e-08 | 6 | 23 | 3 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 2.32e-08 | 6 | 23 | 3 | GO:0020005 | |
| GeneOntologyCellularComponent | symbiont cell surface | 6.49e-08 | 8 | 23 | 3 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 9.73e-08 | 9 | 23 | 3 | GO:0044217 | |
| GeneOntologyCellularComponent | host cellular component | 5.25e-07 | 15 | 23 | 3 | GO:0018995 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 4.11e-04 | 934 | 23 | 6 | GO:0048471 | |
| MousePheno | increased susceptibility to parasitic infection induced morbidity/mortality | 4.78e-07 | 11 | 21 | 3 | MP:0010750 | |
| MousePheno | increased susceptibility to parasitic infection | 9.24e-06 | 91 | 21 | 4 | MP:0005027 | |
| MousePheno | increased heart rate variability | 3.00e-05 | 41 | 21 | 3 | MP:0003928 | |
| MousePheno | abnormal susceptibility to parasitic infection | 3.24e-05 | 125 | 21 | 4 | MP:0020184 | |
| MousePheno | abnormal sinus arrhythmia | 2.07e-04 | 78 | 21 | 3 | MP:0004122 | |
| Domain | GBP_C | 1.69e-07 | 10 | 22 | 3 | PF02841 | |
| Domain | Guanylate-bd_C | 2.33e-07 | 11 | 22 | 3 | IPR003191 | |
| Domain | GBP | 2.33e-07 | 11 | 22 | 3 | PF02263 | |
| Domain | G_GB1_RHD3_dom | 2.33e-07 | 11 | 22 | 3 | IPR030386 | |
| Domain | Guanylate-bd_N | 2.33e-07 | 11 | 22 | 3 | IPR015894 | |
| Domain | G_GB1_RHD3 | 2.33e-07 | 11 | 22 | 3 | PS51715 | |
| Domain | Ank_2 | 1.97e-03 | 215 | 22 | 3 | PF12796 | |
| Domain | Ank | 2.33e-03 | 228 | 22 | 3 | PF00023 | |
| Domain | - | 2.96e-03 | 248 | 22 | 3 | 1.25.40.20 | |
| Domain | ANK | 3.06e-03 | 251 | 22 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 3.13e-03 | 253 | 22 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 3.16e-03 | 254 | 22 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 3.16e-03 | 254 | 22 | 3 | PS50297 | |
| Domain | Ankyrin_rpt | 3.45e-03 | 262 | 22 | 3 | IPR002110 | |
| Domain | - | 1.04e-02 | 746 | 22 | 4 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 1.61e-02 | 848 | 22 | 4 | IPR027417 | |
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 30062052 | ||
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 26416908 | ||
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 32354743 | ||
| Pubmed | GTPase properties of the interferon-induced human guanylate-binding protein 2. | 2.53e-10 | 3 | 23 | 3 | 8706832 | |
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 32620042 | ||
| Pubmed | [Guanylate-binding protein 2 regulates the maturation of mouse dendritic cells induced by β-glucan]. | 2.53e-10 | 3 | 23 | 3 | 29089068 | |
| Pubmed | Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. | 2.53e-10 | 3 | 23 | 3 | 23248289 | |
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 1715024 | ||
| Pubmed | Two families of GTPases dominate the complex cellular response to IFN-gamma. | 2.53e-10 | 3 | 23 | 3 | 9862701 | |
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 11726669 | ||
| Pubmed | GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. | 2.53e-10 | 3 | 23 | 3 | 38636926 | |
| Pubmed | Domain motions, dimerization, and membrane interactions of the murine guanylate binding protein 2. | 2.53e-10 | 3 | 23 | 3 | 36639389 | |
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 16914101 | ||
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 22730319 | ||
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 15717119 | ||
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 35383115 | ||
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 20950129 | ||
| Pubmed | Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. | 1.01e-09 | 4 | 23 | 3 | 7823961 | |
| Pubmed | 1.01e-09 | 4 | 23 | 3 | 36609599 | ||
| Pubmed | 1.01e-09 | 4 | 23 | 3 | 10386861 | ||
| Pubmed | 1.01e-09 | 4 | 23 | 3 | 38404575 | ||
| Pubmed | 1.01e-09 | 4 | 23 | 3 | 8917111 | ||
| Pubmed | 1.01e-09 | 4 | 23 | 3 | 39337476 | ||
| Pubmed | TCR Affinity Biases Th Cell Differentiation by Regulating CD25, Eef1e1, and Gbp2. | 2.52e-09 | 5 | 23 | 3 | 30858199 | |
| Pubmed | 2.52e-09 | 5 | 23 | 3 | 12396730 | ||
| Pubmed | Unique features of different members of the human guanylate-binding protein family. | 2.52e-09 | 5 | 23 | 3 | 17266443 | |
| Pubmed | 2.52e-09 | 5 | 23 | 3 | 21151871 | ||
| Pubmed | Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection. | 2.52e-09 | 5 | 23 | 3 | 31964735 | |
| Pubmed | Murine GBP-2: a new IFN-gamma-induced member of the GBP family of GTPases isolated from macrophages. | 2.52e-09 | 5 | 23 | 3 | 9858320 | |
| Pubmed | 5.05e-09 | 6 | 23 | 3 | 17293456 | ||
| Pubmed | 5.05e-09 | 6 | 23 | 3 | 21757726 | ||
| Pubmed | 8.83e-09 | 7 | 23 | 3 | 20505078 | ||
| Pubmed | TRIF signaling is required for caspase-11-dependent immune responses and lethality in sepsis. | 8.83e-09 | 7 | 23 | 3 | 30587103 | |
| Pubmed | 8.83e-09 | 7 | 23 | 3 | 21502320 | ||
| Pubmed | In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. | 1.41e-08 | 8 | 23 | 3 | 16689661 | |
| Pubmed | Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. | 2.12e-08 | 9 | 23 | 3 | 24739961 | |
| Pubmed | Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. | 2.12e-08 | 9 | 23 | 3 | 33479228 | |
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 3.02e-08 | 10 | 23 | 3 | 28334111 | |
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 4.15e-08 | 11 | 23 | 3 | 24715728 | |
| Pubmed | IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes. | 4.15e-08 | 11 | 23 | 3 | 27693356 | |
| Pubmed | Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. | 4.15e-08 | 11 | 23 | 3 | 18025219 | |
| Pubmed | 5.54e-08 | 12 | 23 | 3 | 35906252 | ||
| Pubmed | 5.54e-08 | 12 | 23 | 3 | 29459437 | ||
| Pubmed | 1.14e-07 | 15 | 23 | 3 | 17114464 | ||
| Pubmed | 1.14e-07 | 15 | 23 | 3 | 25774716 | ||
| Pubmed | 1.71e-07 | 17 | 23 | 3 | 25774715 | ||
| Pubmed | 2.05e-07 | 18 | 23 | 3 | 27001747 | ||
| Pubmed | A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. | 2.43e-07 | 19 | 23 | 3 | 21551061 | |
| Pubmed | Interferon inducible GBPs restrict Burkholderia thailandensis motility induced cell-cell fusion. | 2.86e-07 | 20 | 23 | 3 | 32150572 | |
| Pubmed | 3.33e-07 | 21 | 23 | 3 | 19158679 | ||
| Pubmed | Dimerization and its role in GMP formation by human guanylate binding proteins. | 4.18e-07 | 2 | 23 | 2 | 20923658 | |
| Pubmed | The interferon-inducible GBP1 gene: structure and mapping to human chromosome 1. | 4.18e-07 | 2 | 23 | 2 | 7518790 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 22692453 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 36460216 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 18768830 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 23086406 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 20483731 | ||
| Pubmed | 5.76e-07 | 25 | 23 | 3 | 35139355 | ||
| Pubmed | 9.13e-07 | 29 | 23 | 3 | 33278357 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 33552086 | ||
| Pubmed | Identification of paxillin domains interacting with β-catenin. | 1.25e-06 | 3 | 23 | 2 | 22728435 | |
| Pubmed | Ufbp1 promotes plasma cell development and ER expansion by modulating distinct branches of UPR. | 2.51e-06 | 4 | 23 | 2 | 30842412 | |
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 27036734 | ||
| Pubmed | 9.61e-05 | 371 | 23 | 4 | 15747579 | ||
| Pubmed | 1.64e-04 | 162 | 23 | 3 | 23012479 | ||
| Pubmed | A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties. | 2.05e-04 | 32 | 23 | 2 | 24192035 | |
| Pubmed | 2.18e-04 | 33 | 23 | 2 | 25582440 | ||
| Pubmed | Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stage. | 2.46e-04 | 35 | 23 | 2 | 37890489 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.55e-04 | 588 | 23 | 4 | 38580884 | |
| Interaction | GBP3 interactions | 1.35e-07 | 10 | 22 | 3 | int:GBP3 | |
| Interaction | GBP1 interactions | 1.26e-05 | 42 | 22 | 3 | int:GBP1 | |
| Interaction | GBP2 interactions | 2.70e-05 | 54 | 22 | 3 | int:GBP2 | |
| Cytoband | 1p22.2 | 3.57e-07 | 28 | 23 | 3 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 4.41e-05 | 137 | 23 | 3 | chr1p22 | |
| Cytoband | 16p11.2 | 4.11e-03 | 191 | 23 | 2 | 16p11.2 | |
| GeneFamily | Ankyrin repeat domain containing | 1.40e-03 | 242 | 17 | 3 | 403 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 7.77e-07 | 21 | 23 | 3 | MM651 | |
| Coexpression | GREENBAUM_E2A_TARGETS_DN | 8.99e-07 | 22 | 23 | 3 | MM635 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 1.34e-06 | 25 | 23 | 3 | MM672 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL | 1.88e-06 | 103 | 23 | 4 | M45742 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.27e-05 | 52 | 23 | 3 | MM1118 | |
| Coexpression | DELASERNA_MYOD_TARGETS_DN | 1.86e-05 | 59 | 23 | 3 | MM659 | |
| Coexpression | MIKKELSEN_NPC_LCP_WITH_H3K4ME3 | 2.16e-05 | 62 | 23 | 3 | MM865 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN | 2.60e-05 | 200 | 23 | 4 | M3127 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN | 2.60e-05 | 200 | 23 | 4 | M7807 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 5.37e-05 | 84 | 23 | 3 | MM1049 | |
| Coexpression | SEKI_INFLAMMATORY_RESPONSE_LPS_UP | 5.96e-05 | 87 | 23 | 3 | MM1253 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 6.17e-05 | 88 | 23 | 3 | MM1087 | |
| Coexpression | HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 6.66e-05 | 14 | 23 | 2 | M41166 | |
| Coexpression | QI_PLASMACYTOMA_UP | 8.48e-05 | 271 | 23 | 4 | MM1045 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 8.50e-05 | 98 | 23 | 3 | MM460 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 9.03e-05 | 100 | 23 | 3 | MM458 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL | 1.79e-04 | 126 | 23 | 3 | M45721 | |
| Coexpression | LI_INDUCED_T_TO_NATURAL_KILLER_UP | 2.10e-04 | 343 | 23 | 4 | MM1059 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 2.19e-04 | 135 | 23 | 3 | MM753 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 2.34e-04 | 138 | 23 | 3 | MM1047 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP | 2.36e-04 | 26 | 23 | 2 | M41741 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 2.55e-04 | 142 | 23 | 3 | MM840 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 2.71e-04 | 145 | 23 | 3 | MM3744 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 3.36e-04 | 156 | 23 | 3 | MM3763 | |
| Coexpression | HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 3.55e-04 | 159 | 23 | 3 | M40998 | |
| Coexpression | GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP | 3.82e-04 | 163 | 23 | 3 | M8663 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN | 3.83e-04 | 33 | 23 | 2 | M41194 | |
| Coexpression | GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 3.95e-04 | 165 | 23 | 3 | M8992 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 4.62e-04 | 174 | 23 | 3 | MM836 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 4.77e-04 | 176 | 23 | 3 | MM1048 | |
| Coexpression | HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 6.21e-04 | 42 | 23 | 2 | M41024 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH2_UP | 6.43e-04 | 195 | 23 | 3 | M5424 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 6.63e-04 | 197 | 23 | 3 | M5853 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN | 6.63e-04 | 197 | 23 | 3 | M5879 | |
| Coexpression | GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | 6.73e-04 | 198 | 23 | 3 | M5861 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 6.73e-04 | 198 | 23 | 3 | MM17083 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP | 6.83e-04 | 199 | 23 | 3 | M4063 | |
| Coexpression | GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | 6.83e-04 | 199 | 23 | 3 | M5874 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 6.83e-04 | 199 | 23 | 3 | M5264 | |
| Coexpression | GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN | 6.93e-04 | 200 | 23 | 3 | M3276 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN | 6.93e-04 | 200 | 23 | 3 | M8506 | |
| Coexpression | KRIEG_KDM3A_TARGETS_NOT_HYPOXIA | 6.93e-04 | 200 | 23 | 3 | M2468 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_8_PRECICTIVE_ICB_RESPONSE | 6.93e-04 | 200 | 23 | 3 | MM17082 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN | 6.93e-04 | 200 | 23 | 3 | M9593 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 8.77e-04 | 217 | 23 | 3 | MM1156 | |
| Coexpression | HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 1.05e-03 | 231 | 23 | 3 | M40995 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 1.10e-03 | 235 | 23 | 3 | MM978 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-06 | 163 | 23 | 4 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 126 | 23 | 3 | 4eeea015efe17e0aae5bd76b71fa70b5149dfada | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-05 | 157 | 23 | 3 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-05 | 157 | 23 | 3 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.42e-05 | 160 | 23 | 3 | a76ad44b5f25f59d6b9333fb45f8bb96196a3090 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.42e-05 | 160 | 23 | 3 | af84da18c85037f49f55e8958f00f12140226982 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.42e-05 | 160 | 23 | 3 | f7ca98beaa24f9674d503588eb15d341c4135d77 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-6|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 7.70e-05 | 162 | 23 | 3 | 0e8fb83acb8ea9905cc3ca985feb8a00931549ff | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.13e-05 | 165 | 23 | 3 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.13e-05 | 165 | 23 | 3 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 167 | 23 | 3 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 172 | 23 | 3 | 910ec7794ea4000db4ef1e2c34e08dbc0243df2c | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 173 | 23 | 3 | 37825d0dda028cf677ff6ff16ea58bff75cb25a7 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 173 | 23 | 3 | 35dc897e06f905419d44093a92170d2cec35dd51 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.03e-04 | 179 | 23 | 3 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-Memory_B_cells|Liver / Manually curated celltypes from each tissue | 1.07e-04 | 181 | 23 | 3 | a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1 | |
| ToppCell | COVID-19_Severe-Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.07e-04 | 181 | 23 | 3 | aa5e5fb0308b5e2ef918548c85529c9a433c57f5 | |
| ToppCell | COVID-19_Severe-Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.07e-04 | 181 | 23 | 3 | 5e5101195d5ff8c8ea7ddcf0bc4f4e03e64c01e0 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.10e-04 | 183 | 23 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 184 | 23 | 3 | d18e94839a62fca536ae1630c154e5d0aafc44c5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 185 | 23 | 3 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 186 | 23 | 3 | 246503fd4e6ae24041c606b069eb5fb313e60f73 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 186 | 23 | 3 | ef93ac469eb4f63db036f14b442c1503b8c6de38 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.20e-04 | 188 | 23 | 3 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-04 | 188 | 23 | 3 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.20e-04 | 188 | 23 | 3 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 23 | 3 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | 10x5'-Liver-Lymphocytic_B|Liver / Manually curated celltypes from each tissue | 1.21e-04 | 189 | 23 | 3 | 1ebff8185060d78f27f8d887e9adaa5f8faf2196 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.25e-04 | 191 | 23 | 3 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 191 | 23 | 3 | 89d03c4133dda852a3713c0902a7d67941cf5b21 | |
| ToppCell | Leuk-UTI|World / Disease, Lineage and Cell Type | 1.29e-04 | 193 | 23 | 3 | 26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-STAT1+_Naive_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 194 | 23 | 3 | a478947715e7ef7994040c7c661ff3a3e776b5fc | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.33e-04 | 195 | 23 | 3 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | 15-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 1.35e-04 | 196 | 23 | 3 | 0e45817625b96d21a8cc4dfbbd465ee6403b6802 | |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.35e-04 | 196 | 23 | 3 | ded44b38ea489946e9eedfe752b5a9fde9149c16 | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.37e-04 | 197 | 23 | 3 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 1.39e-04 | 198 | 23 | 3 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-04 | 199 | 23 | 3 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | Sepsis-Leuk-UTI|Sepsis / Disease, condition lineage and cell class | 1.44e-04 | 200 | 23 | 3 | 7d92b24c0c888dd46e40b7e3c6c2645c3604f132 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 200 | 23 | 3 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-03 | 101 | 23 | 2 | 86acaa2502f61baa714ae988b73e3e73a71e897e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Cd74|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-03 | 115 | 23 | 2 | 4c7d78a246f1b44846fb959359515ef185530053 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease condition and Cell class | 1.61e-03 | 116 | 23 | 2 | e3d1a90a229f5697b2b715574bb96790a435f73b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.66e-03 | 118 | 23 | 2 | f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-03 | 118 | 23 | 2 | 0dcac16eea8e7978de370a815da9a0cdd212598e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-03 | 118 | 23 | 2 | 7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.66e-03 | 118 | 23 | 2 | c5c6724e0e526d7c2fc8cabff4a112a900ec997f | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 1.69e-03 | 119 | 23 | 2 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.72e-03 | 120 | 23 | 2 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | Endothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4) | 1.78e-03 | 122 | 23 | 2 | 2cb8bb63c69aed4d4504b9d97219b8707666f950 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-03 | 124 | 23 | 2 | d88bce8a4f023d5b617b2e8e372a94bd1248d20d | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 125 | 23 | 2 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-03 | 127 | 23 | 2 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | ASK452-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.08e-03 | 132 | 23 | 2 | 49ba24e24b3127b5257a88a0ee0246c9843c580a | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Proliferative_AT1_Progenitor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.11e-03 | 133 | 23 | 2 | b0d3ac5abd9ebd490db46a3ef2e4ae88c4bf4e34 | |
| ToppCell | Mild/Remission-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.14e-03 | 134 | 23 | 2 | 5bd1e3fa6278facd9e949e9e5e244e700190126b | |
| ToppCell | Mild/Remission-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.20e-03 | 136 | 23 | 2 | 1b3c6edcbe0eb674d2d9c838e83ebe2b93e3eec1 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.23e-03 | 137 | 23 | 2 | 2544d1256f11da6e3bad24a871b2253e0ab20d01 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.23e-03 | 137 | 23 | 2 | 874e2eaa7846a2832f46b77c726d79f220a4a1cd | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 2.30e-03 | 139 | 23 | 2 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | Mild/Remission-B_intermediate-14|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.36e-03 | 141 | 23 | 2 | 69e32125a0e8f0c8561e5e7a93607f368f09546f | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-03 | 142 | 23 | 2 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-03 | 142 | 23 | 2 | 66135fee18448cc09a78bc6ede05afd63c72ae21 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.43e-03 | 143 | 23 | 2 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-03 | 144 | 23 | 2 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-03 | 144 | 23 | 2 | fca32b38d23fa4d213e553b929604a2796e9a929 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-03 | 145 | 23 | 2 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.60e-03 | 148 | 23 | 2 | 6ffa212f0cc44c40d2143816dc6cfd82fbf09a33 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.63e-03 | 149 | 23 | 2 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-03 | 149 | 23 | 2 | a6e192bf9bcf3b219e618c465bc451f7c86f49f1 | |
| ToppCell | PND28|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-03 | 149 | 23 | 2 | d3a025440c8ad284a9291c902403e5888d28e90b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.63e-03 | 149 | 23 | 2 | 54c9c6282f5f5de43dfaf2972fab3e3dcf9838a3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.63e-03 | 149 | 23 | 2 | 14d2e8cab97108d8fa94e540c1957b73ed32dc73 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-03 | 149 | 23 | 2 | efa30fcd9370f98eb7445f295eb4d0305ff455c3 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.70e-03 | 151 | 23 | 2 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-03 | 151 | 23 | 2 | ea62e92ccb984f44559b434f35c1c4450767c8f1 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.74e-03 | 152 | 23 | 2 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 2.74e-03 | 152 | 23 | 2 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-03 | 153 | 23 | 2 | a8f83ec640fae51d4fba34b92e3d6cca4999e930 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-03 | 153 | 23 | 2 | da1bff9928d8c61bb1c389d45fd897cfa4bed023 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.85e-03 | 155 | 23 | 2 | d336559092563b0d7776eef873f1d2759aca45f7 | |
| ToppCell | Adult-Immune-B_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.85e-03 | 155 | 23 | 2 | 5857aebd43b901fc9f8c46f2d628582969db9e6a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-03 | 155 | 23 | 2 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.85e-03 | 155 | 23 | 2 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.88e-03 | 156 | 23 | 2 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-03 | 156 | 23 | 2 | 4e4b94580969a9736ca28df79715535a4bd1f9b2 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-03 | 157 | 23 | 2 | 2c767c526abcc8adea6ec4eb2cc333060bb213b5 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-03 | 157 | 23 | 2 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | Control-Lymphocyte-T_NK-dnT|Control / Disease, Lineage and Cell Type | 2.95e-03 | 158 | 23 | 2 | 7a2fad6426549d910834debfe5e102fe2ab5976d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-03 | 158 | 23 | 2 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-03 | 158 | 23 | 2 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-3|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.95e-03 | 158 | 23 | 2 | ec1a71b8f46179642b5af20e27764bb43c4b8e99 | |
| ToppCell | Adult-Immune-mast_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.99e-03 | 159 | 23 | 2 | 9f53fe2e0f25448d62a591c8e528e9a49b5400d5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 2.99e-03 | 159 | 23 | 2 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 2.99e-03 | 159 | 23 | 2 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 2.99e-03 | 159 | 23 | 2 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-03 | 160 | 23 | 2 | 5c9281706009558c8361bfa76169f43ffc0f7947 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-03 | 160 | 23 | 2 | 6005948e400e781cdb876ba350b3ec8991e3945f | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 3.03e-03 | 160 | 23 | 2 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| Computational | Immune response and Ag processing and presentation. | 4.13e-04 | 126 | 13 | 3 | MODULE_345 | |
| Computational | Genes in the cancer module 292. | 5.16e-04 | 136 | 13 | 3 | MODULE_292 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_INTERFERON | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_INTERFERON | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Disease | Acute kidney injury | 1.72e-04 | 25 | 23 | 2 | HP_0001919 | |
| Disease | Bilateral Wilms Tumor | 2.33e-04 | 29 | 23 | 2 | C2930471 | |
| Disease | Myocardial Ischemia | 3.38e-04 | 176 | 23 | 3 | C0151744 | |
| Disease | Nephroblastoma | 3.60e-04 | 36 | 23 | 2 | C0027708 | |
| Disease | cognitive function measurement | 6.44e-04 | 1434 | 23 | 6 | EFO_0008354 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 7.10e-04 | 227 | 23 | 3 | EFO_0004346, EFO_0010736 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 3.53e-03 | 398 | 23 | 3 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | colorectal cancer (is_implicated_in) | 3.99e-03 | 121 | 23 | 2 | DOID:9256 (is_implicated_in) | |
| Disease | verbal-numerical reasoning measurement | 4.66e-03 | 131 | 23 | 2 | EFO_0008394 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPKLWPQLAGTKTLH | 6 | Q14236 | |
| LPTIKWKPLIHSPSR | 426 | Q9NZJ5 | |
| PSIPQLKEHLRKHWT | 341 | Q7Z2E3 | |
| SQVRHLKHTPWPPTL | 46 | Q14161 | |
| IPPLVHCADKSLPWK | 276 | Q6W2J9 | |
| LPVVVKLLHPPSHWP | 491 | P35222 | |
| KLLHPPSHWPLIKAT | 496 | P35222 | |
| WCVPHPKKPGHILVL | 81 | P32455 | |
| WCVPHPKKPEHTLVL | 81 | P32456 | |
| WCVPHPKKPEHTLVL | 81 | Q9H0R5 | |
| PWPKHSLKHRVKKSP | 221 | Q9BXP8 | |
| KPLLPILHWLKHPGD | 181 | Q9P2J9 | |
| PLSWTHVHPKGPKSL | 211 | P15391 | |
| LHKIPLPPWALIAIA | 51 | P21579 | |
| THLPSHLIPPSIWKE | 116 | Q6IMI6 | |
| KQKHLPHFKPWLHPE | 226 | Q9Y365 | |
| HLTLPKKVPMLTWPS | 186 | O94966 | |
| HEKPWLPPPLILLSH | 1096 | Q9BX84 | |
| PKLPNLSPLAIKHLW | 116 | Q2NKQ1 | |
| SALLHLHPPWKSPAM | 471 | Q9BQI6 | |
| HLHIVPCKHVLSWPP | 151 | Q96NZ8 | |
| IPPAKLPELHSHWLL | 221 | Q9BR11 | |
| TSLAHELWKVPLPPK | 1711 | Q8NDV7 | |
| HKLKPWLLEVNHSPS | 381 | A6NNM8 |